Certain symptoms warrant prompt medical evaluation to distinguish between expected side effects, IBS exacerbation, and potentially serious complications
Understanding GLP-1 Weight Loss Medications Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized obesity treatment, but their benefits extend far beyond simple appetite suppression
In addition to having a greater reduction in BMI and total daily insulin use, the GLP-1 group had better preservation of glomerular filtration rate and creatinine levels at 3- and 6-month follow-ups than the group that did not receive a GLP-1
Here, we report the genome-wide reversal of transcriptomic aging signatures in multiple major brain cell types, including glial and mural cells, by systemic glucagon-like peptide-1 receptor (GLP-1R) agonist (GLP-1RA) treatment
NAD+ is known to exert significant anti-inflammatory actions within body and may be used to reduce the inflammation that typically occurs with pain and, thereby, offer some relief from pain